Curative thoraco-systemic therapy plus local treatment to the brain for extensive disease-small-cell lung cancer with metastasis only to the brain

Author:

Shibata Kazuhiko1ORCID,Iwasa Keiichi1,Takanaka Tsuyoshi2,Yachi Tsuyoshi3,Okazaki Akihito4,Shiba Yasutaka4,Kasahara Kazuo5

Affiliation:

1. Division of Medical Oncology, Department of Medicine, Kouseiren Takaoka Hospital 5-10 Eirakumachi, Takaoka, Toyama, Japan

2. Department of Radiation Oncology, Kouseiren Takaoka Hospital, 5-10 Eirakumachi, Takaoka, Toyama, Japan

3. Department of Thoracic and Cardiovascular Surgery, Kouseiren Takaoka Hospital, 5-10 Eirakumachi, Takaoka, Toyama, Japan

4. Division of Respiratory Medicine, Department of Medicine, Kouseiren Takaoka Hospital, 5-10 Eirakumachi, Takaoka, Toyama, Japan

5. Department of Hematology and Respiratory Medicine, Kanazawa University Graduate School of Medicine, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan

Abstract

Abstract We reviewed 11 cases of extensive disease (ED)-SCLC and metastasis only to the brain treated during 2011–14. All patients underwent definitive therapy similar to that for limited disease (LD), combined with local treatment for BM. We compared the survival outcomes of these patients to those of patients with LD (n = 29) or other ED (n = 38) during the same period. Three patients had progression of BM at completion of chemotherapy. Ten patients received whole-brain radiotherapy (4 prophylactic, 6 therapeutic), and remaining one elderly patient underwent stereotactic radiosurgery. Finally, 8 and 3 patients achieved a CR or PR of BM, respectively. Five remained free of progression for 21.1–73.2 months. The progression-free and overall survival outcomes of ED-SCLC with brain only metastases were comparable to those of LD and superior to those of other ED. In conclusion, ED-SCLC with metastasis limited to the brain could be treated with curative intent.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3